# ATSF NW Office – FDA Inspection, Jan 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/atsf-nw-office/865e33e0-2fe8-4193-8136-71375fdf19ac
Source feed: FDA_Inspections

> FDA inspection 1195105 of ATSF NW Office, January 11, 2023. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195105
- Company Name: ATSF NW Office
- Inspection Date: 2023-01-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1339400 - 2026-09-18
- FDA Inspection 1061150 - 2018-07-09
- FDA Inspection 985587 - 2016-09-16
- FDA Inspection 908774 - 2014-12-12

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/john-a-iwen/b71cb474-8485-416e-a534-ffaed0319625)

Company: https://www.keypedia.com/companies/atsf-nw-office/b47f460a-adab-488c-92ac-537b4edac41e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d